Results 1 to 10 of about 1,598,143 (384)

Spatial transcriptomic profiling of coronary endothelial cells in SARS-CoV-2 myocarditis

open access: yesFrontiers in Medicine, 2023
ObjectivesOur objective was to examine coronary endothelial and myocardial programming in patients with severe COVID-19 utilizing digital spatial transcriptomics.BackgroundSevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has well-established ...
Camilla Margaroli   +37 more
doaj   +1 more source

Diet, microbiota, and the mucus layer: The guardians of our health

open access: yesFrontiers in Immunology, 2022
The intestinal tract is an ecosystem in which the resident microbiota lives in symbiosis with its host. This symbiotic relationship is key to maintaining overall health, with dietary habits of the host representing one of the main external factors ...
Francesco Suriano   +3 more
doaj   +1 more source

Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration

open access: yesFrontiers in Neuroscience, 2021
The human tau protein is implicated in a wide range of neurodegenerative “tauopathy” diseases, consisting of Alzheimer’s disease (AD) and frontotemporal lobar degeneration which includes progressive supranuclear palsy, corticobasal degeneration, Pick’s ...
Ben Boyarko, Vivian Hook, Vivian Hook
doaj   +1 more source

Investigating Fungi-Derived Bioactive Molecules as Inhibitor of the SARS Coronavirus Papain Like Protease: Computational Based Study

open access: yesFrontiers in Medicine, 2021
Due to the rapid growth of the COVID-19 pandemic and its outcomes, developing a remedy to fight the predicament is critical. So far, it has infected more than 214,468,601 million people and caused the death of 4,470,969 million people according to the ...
Aweke Mulu Belachew   +3 more
doaj   +1 more source

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

open access: yesScience, 2020
Targeting a key enzyme in SARS-CoV-2 Scientists across the world are working to understand severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). Zhang et al.
Linlin Zhang   +8 more
semanticscholar   +1 more source

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

open access: yesScience, 2020
Promising antiviral protease inhibitors With no vaccine or proven effective drug against the virus that causes coronavirus disease 2019 (COVID-19), scientists are racing to find clinical antiviral treatments.
Wenhao Dai   +26 more
semanticscholar   +1 more source

Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1

open access: yesFrontiers in Cardiovascular Medicine, 2021
The lectin-like oxidized-LDL (oxLDL) receptor LOX-1, which is broadly expressed in vascular cells, represents a key mediator of endothelial activation and dysfunction in atherosclerotic plaque development.
Torben Mentrup   +2 more
doaj   +1 more source

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

open access: yesNature Communications, 2021
COVID-19 caused by the SARS-CoV-2 virus has become a global pandemic. 3CL protease is a virally encoded protein that is essential across a broad spectrum of coronaviruses with no close human analogs.
B. Boras   +51 more
semanticscholar   +1 more source

Peroxisomal Proteostasis Involves a Lon Family Protein That Functions as Protease and Chaperone [PDF]

open access: yes, 2012
Proteins are subject to continuous quality control for optimal proteostasis. The knowledge of peroxisome quality control systems is still in its infancy. Here we show that peroxisomes contain a member of the Lon family of proteases (Pln).
Aksam   +58 more
core   +10 more sources

Reprogramming of the Caseinolytic Protease by ADEP Antibiotics: Molecular Mechanism, Cellular Consequences, Therapeutic Potential

open access: yesFrontiers in Molecular Biosciences, 2021
Rising antibiotic resistance urgently calls for the discovery and evaluation of novel antibiotic classes and unique antibiotic targets. The caseinolytic protease Clp emerged as an unprecedented target for antibiotic therapy 15 years ago when it was ...
Heike Brötz-Oesterhelt   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy